Blood cancer dosing trial aims to Fine-Tune treatment
Knowledge-focused
Not yet recruiting
This study is for adults with blood cancers like multiple myeloma or Waldenstrom macroglobulinaemia. It compares different treatment doses to see which works best and has the fewest side effects. The goal is to improve survival and quality of life by finding the optimal dose for …
Phase: PHASE4 • Sponsor: Anne Louise Tølbøll Sørensen • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC